Literature DB >> 1445888

Tissue-specific alternative splicing of the first exon generates two types of mRNAs in human aromatic L-amino acid decarboxylase.

H Ichinose1, C Sumi-Ichinose, T Ohye, Y Hagino, K Fujita, T Nagatsu.   

Abstract

Aromatic-L-amino-acid decarboxylase (AADC) is an enzyme that plays an essential role in synthesizing catecholamines and serotonin in neuronal and endocrine tissues. AADC has also been detected in other nonneuronal tissues including liver and kidney, although its physiological role in nonneuronal tissues has not yet been defined. Previously we have cloned a human AADC cDNA from a neuronal tissue (pheochromocytoma) [Ichinose, H., Kurosawa, Y., Titani, K., Fujita, K., & Nagatsu, T. (1989) Biochem. Biophys. Res. Commun. 164, 1024-1030] and the corresponding genomic DNA [Sumi-Ichinose, C., Ichinose, H., Takahashi, E., Hori, T., & Nagatsu, T. (1992) Biochemistry 31, 2229-2238]. Here we present isolation and characterization of AADC cDNA and genomic DNA from a nonneuronal tissue (human liver). The nonneuronal and neuronal AADC mRNAs differed only in the region corresponding to the untranslated first exon. The first exon for the nonneuronal-type mRNA was located 4.2 kilobases upstream to that for the neuronal-type mRNA and 22 kilobases from exon 2, to which it is spliced. Determination of the transcription initiation site indicated that the length of the nonneuronal-type exon 1 was 200 bp. A TATA box-like motif was located between positions -26 and -20 from the transcription initiation site. These results showed that an alternative usage of the first exon in the 5'-untranslated regions produces two types of mRNAs in AADC and suggested that alternative splicing would regulate the tissue-specific expression of AADC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445888     DOI: 10.1021/bi00161a036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  L-Dopa decarboxylase expression profile in human cancer cells.

Authors:  Ioanna Chalatsa; Eleftheria Nikolouzou; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Mol Biol Rep       Date:  2010-06-11       Impact factor: 2.316

Review 2.  Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme.

Authors:  M D Berry; A V Juorio; X M Li; A A Boulton
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

3.  l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer.

Authors:  Christos Patsis; Vasiliki Glyka; Ioannis Yiotakis; Emmanuel G Fragoulis; Andreas Scorilas
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

4.  Identification and characterization of a novel form of the human L-dopa decarboxylase mRNA.

Authors:  Dido Vassilacopoulou; Diamantis C Sideris; Alice G Vassiliou; Emmanuel G Fragoulis
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

5.  L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas.

Authors:  Dimitra Florou; Iordanis N Papadopoulos; Emmanuel G Fragoulis; Andreas Scorilas
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-12       Impact factor: 4.553

6.  Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.

Authors:  Latif A Wafa; Helen Cheng; Mira A Rao; Colleen C Nelson; Michael Cox; Martin Hirst; Ivan Sadowski; Paul S Rennie
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

7.  Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.

Authors:  C K Kontos; I N Papadopoulos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

Review 8.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

9.  Genomic imprinting of Dopa decarboxylase in heart and reciprocal allelic expression with neighboring Grb10.

Authors:  Trevelyan R Menheniott; Kathryn Woodfine; Reiner Schulz; Andrew J Wood; David Monk; Andrew S Giraud; H Scott Baldwin; Gudrun E Moore; Rebecca J Oakey
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

10.  Expression of human tyrosine hydroxylase-chloramphenicol acetyltransferase (CAT) fusion gene in the brains of transgenic mice as examined by CAT immunocytochemistry.

Authors:  I Nagatsu; N Karasawa; K Yamada; M Sakai; T Fujii; T Takeuchi; R Arai; K Kobayashi; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.